BCR and chronic myelogenous leukemia, BCR-ABL1 positive: EGCG-mono-palmitate (EGCG-MP), a highly active derivative of EGCG effectively activated Src homology 2 domain-containing tyrosine phosphatase-1 (SHP-1) which consequentially resulted in reduction of phosphorylated levels of BCR-ABL and signal transducer and activator of transcription 3 (STAT3) in human chronic myeloid leukemia (CML) cells (shown in Figure 1) [6].